Lack of Discernible Benefit of High-Dose Aspirin in the Treatment of Kawasaki Disease
In a retrospective single-center cohort study of 460 children with Kawasaki Disease, initial treatment with low-dose aspirin and intravenous immunoglobulin (IVIG) resulted in similar coronary artery outcomes and IVIG retreatment rates compared to high-dose aspirin and IVIG. These findings support consideration of low-dose aspirin for the management of acute-phase Kawasaki Disease.
Authors
- Shulman St
- Kwang-Youn Kim (ORCID: https://orcid.org/0000-0002-0868-5134)
- Huthaifah Khan
- Lavina Thadani
- Anne Rowley
Institutions
- Northwestern University (US)
- Lurie Children's Hospital (US)
- University of Missouri–Kansas City (US)
Publication Details
- Journal
- Journal of the Pediatric Infectious Diseases Society
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1093/jpids/piag002
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00